USA Financial Formulas’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

USA Financial Formulas’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4	Closed	-$169	–	553
2023 Q2	$169	Hold	4	–	–	﹤0.01%	486
2023 Q1	$142	Buy	+4	New	+$145	﹤0.01%	420
2022 Q3	$0	Hold	4	–	–	﹤0.01%	444
2022 Q2	$0	Hold	4	–	–	﹤0.01%	468
2022 Q1	$0	Buy	+4	New	+$338	﹤0.01%	518
2021 Q4	–	Sell	-3,996	Closed	-$350K	–	513
2021 Q3	$350K	Buy	+3,996	New	+$362K	0.31%	98
2020 Q3	–	Sell	-1,483	Closed	-$86K	–	371
2020 Q2	$86K	Sell	1,483 -1,696	-53%	-$91.2K	0.06%	74
2020 Q1	$125K	Buy	+3,179	New	+$186K	0.08%	120

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

USA Financial Formulas's SYNH Position: Q3 2023 in Review

USA Financial Formulas sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 4 shares — an estimated $169 sold.

USA Financial Formulas first reported a position in SYNH in Q1 2020 and held it in 8 quarters. The position peaked at $350K in Q3 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

USA Financial Formulas reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
USA Financial Formulas sold 4 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $169.
USA Financial Formulas first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2020 and held it in 8 quarters.
USA Financial Formulas's Syneos Health, Inc. Class A Common Stock position peaked at $350K in Q3 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on USA Financial Formulas's 13F filing for Q3 2023, filed 27 Nov 2023.